NCT00266721View on ClinicalTrials.gov

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

October 31, 2000

Conditions
Postprandial BloatingPostprandial BelchingPostprandial Eructation
Interventions
DRUG

Pancrelipase (Creon) 2 tablets with each meal

Trial Locations (1)

55417

VAMC, Minneapolis

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00266721 - Efficacy of Pancrelipase on Postprandial Belching and Bloating. | Biotech Hunter | Biotech Hunter